Gastrointestinal

The Pharmacy Times® Gastrointestinal resource center provides news and articles centered around the FDA approved drugs in gastroenterology, as well as links to condition-specific resources, and videos and other content.

What can we help you find?

Antibiotic Use in Infants May Increase Risk of Inflammatory Bowel Disease Later in Life

According to a study published in Genome Medicine, the disruption of gut bacteria through the use of antibiotics soon after birth has the ability to affect the immune system’s process of maturation.

FDA Approves Biosimilar to Humira

Mylan plans to launch adalimumab-fkjp in the United States in July 2023.

Survey Finds Association Between Proton Pump Inhibitors, Risk of COVID-19

According to an online survey of more than 53,000 Americans using PPIs, once or twice daily use significantly increases the likelihood of a positive test for COVID-19.

Inflammatory Bowel Disease Linked to More Than Doubled Risk of Dementia

According to a recent study published in Gut, inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn disease, is associated with a more than doubled likelihood of developing dementia.

Study: High-Salt Diet Impacts Health of Gut Microbiome

Reducing salt intake to a healthier level appears to be beneficial for the gut microbiome and blood pressure, especially in females with untreated hypertension, according to researchers at the Medical College of Georgia at Augusta University.

Diet Interactions With Gut Microbes Affect Cancer Treatment Outcomes

According to a recent study, diet can affect the outcome of chemotherapy due to microbes in the gut that can trigger changes in a patient’s response to drugs.

Study: Certain Foods Common in Diets of US Adults with Inflammatory Bowel Disease

The researchers analyzed the National Health Interview Survey 2015 to determine the food intake and frequency of consumption for US adults with IBD.

Cholesterol-lowering Statins May Improve Gut Health in Obese People

In a new study, researchers analyzed gut microbiota to understand further the links between gut health and obesity.

Monday Pharmaceutical Mystery: April 27

Why was a patient prescribed something normally used for stomach problems to help her produce breastmilk?

Generic Products (April 2020)

Generic products featured in the April 2020 issue.

Survey Shows Adopting New Vancomycin Guidelines is Priority for Pharmacists Despite Pandemic

A survey conducted between March 30 to April 6 by InsightRx found that implementing the new vancomycin guidelines into the pharmacy community is as important as the coronavirus disease 2019 (COVID-19) in the healthcare system.

Patients With Inflammatory Bowel Disease Not At Higher Risk of COVID-19, Should Continue Therapies

The clinical practice update incorporates emerging evidence and available guidance for patients with IBD.

The Pharmacy Times® Gastrointestinal resource center provides a source of all the latest clinical information, with articles covering updates from the robust pipeline of novel GI therapies, and the newest data from all phases of clinical trials and studies in the space. It also serves as a hub of information and news from the upcoming and ongoing conferences and annual meetings of gastrointestinal associations and societies, including pivotal coverage right from the floor.

Among its other resources are a wealth of videos including interviews with thought leaders and experts in GI, and moderated Peer Exchange panel discussions about the best practices and key methods for treating complex cases of conditions such as: constipation, irritable bowel syndrome, hemorrhoids, anal fissures, perianal abscesses, anal fistulas, perianal infections, diverticular diseases, colitis, colon polyps and cancer.